Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Colorectal Cancer
Interventions: Drug: systemic chemotherapy; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Biological: ramucirumab; Drug: irinotecan hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Interventions: Behavioral: Stepped CRCS Interventions; Behavioral: Control
Sponsors: The University of Texas Health Science Center, Houston; Duke University; Boston University
Recruiting - verified March 2010
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Condition: Colorectal Neoplasms
Interventions: Drug: Glutamine; Drug: Calcium and Magnesium
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: BMS-908662; Drug: BMS-908662; Drug: Cetuximab
Sponsors: Bristol-Myers Squibb; Genzyme
Not yet recruiting - verified March 2010
Conditions: Bladder Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastrointestinal Complications; Long-term Effects Secondary to Cancer Therapy in Adults; Ovarian Cancer; Prostate Cancer; Radiation Toxicity; Sarcoma; Testicular Germ Cell Tumor; Vaginal Cancer
Interventions: Other: questionnaire administration; Procedure: gastrointestinal complications management/prevention; Procedure: quality-of-life assessment
Sponsor: Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010
Condition: Colorectal Cancer Screening
Intervention: Behavioral: Tailored interactive intervention to increasing CRCS
Sponsors: The University of Texas Health Science Center, Houston; National Cancer Institute (NCI)
Completed - verified March 2010
Condition: Colorectal Neoplasms
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Conditions: Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms
Intervention: Behavioral: Psychosocial rehabilitation course
Sponsors: Danish Cancer Society; University Hospital Århus, Department of Surgery; University Hospital Århus, Urology Department; Regional Hospital Randers, Department of Colorectal Surgery; Regional Hospital Hørsholm, Department of Breast Surgery
Completed - verified March 2010
Condition: Colorectal Cancer
Intervention: Dietary Supplement: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010
Conditions: Stage IV Colorectal Cancer; Dignity Therapy
Intervention: Behavioral: Dignity Therapy
Sponsor: Northwestern University
Not yet recruiting - verified February 2010
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Mek Inhibitor MSC1936369B; Drug: Mek Inhibitor MSC1936369B; Drug: Placebo; Drug: FOLFIRI
Sponsor: EMD Serono
Recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention: Drug: Erbitux (Cetuximab)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Conditions: Length of Stay; Complications; Adverse Drug Event; Quality of Life; Hospital Costs
Interventions: Procedure: Laparoscopic Surgery for Colorectal Cancer; Drug: XELOX Chemotherapy; Drug: mFolfox6 chemotherapy; Other: Fast Track Perioperative Treatment; Other: Conventional Perioperative Treatment; Procedure: Open Surgery for Colorectal Cancer
Sponsor: Zhejiang University
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Procedure: Immunochemical fecal occult blood test And colonoscopy if test is positive; Procedure: Colonoscopy with sedation
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Recruiting - verified September 2008
Condition: Colorectal Neoplasm
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Hepatic Metastases; Colorectal Cancer
Intervention: Procedure: Routine hilar lymphadenectomy
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Condition: Colorectal Cancer
Interventions: Behavioral: Multimedia Education; Behavioral: Print Media; Behavioral: Usual and customary waiting room process
Sponsors: Saint Francis Care; American Cancer Society; Feinberg School of Medicine, Northwestern University
Recruiting - verified February 2010
Condition: Metastatic Colorectal Cancer
Interventions: Drug: ARQ 197 + cetuximab + irinotecan; Drug: Placebo + cetuximab + irinotecan
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Drug: BVZ+XELOX or BVZ+XELIRI or BVZ+FUIRI or BVZ+FUOX; Drug: BVZ+XELOX
Sponsors: Spanish Cooperative Group for Gastrointestinal Tumour Therapy; Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
All Categories ... by Medical Condition » ... Cancers » ... Colon Cancer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
